Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4- Thiadiazole
2. Cl 64 855
3. Cl 64,855
4. Cl 64855
1. Nitroimidazole Thiadiazole
2. 19622-55-0
3. Cl 64855
4. 2-amino-5-(1-methyl-5-nitroimidazol-2-yl)-1,3,4-thiadiazole
5. 1,3,4-thiadiazol-2-amine, 5-(1-methyl-5-nitro-1h-imidazol-2-yl)-
6. Nsc265726
7. 2-amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole
8. Ccris 2480
9. Nsc 265726
10. Brn 0619299
11. 5-(1-methyl-5-nitroimidazol-2-yl)-1,3,4-thiadiazol-2-amine
12. Cl 64 855
13. Cl 64,855
14. 1,3,4-thiadiazole, 2-amino-5-(1-methyl-5-nitroimidazol-2-yl)-
15. Unii-vq8uh664zj
16. Vq8uh664zj
17. Chembl423172
18. Schembl11696315
19. Dtxsid50173298
20. Zinc17061909
21. Nsc-265726
22. Cl-64855
23. Nci60_002137
24. Hy-119480
25. Cs-0068483
26. Q3304399
27. 1,4-thiadiazole, 2-amino-5-(1-methyl-5-nitroimidazol-2-yl)-
28. 2-(2-amino-1,3,4-thiadiazol-5-yl)-1-methyl-5-nitroimidazole
29. 5-(1-methyl-5-nitro-imidazol-2-yl)-1,3,4-thiadiazol-2-amine
30. 1,4-thiadiazol-2-amine, 5-(1-methyl-5-nitro-1h-imidazol-2-yl)-
31. 5-(1-methyl-5-nitro-1h-imidazol-2-yl)-1,3,4-thiadiazol-2-amine
| Molecular Weight | 226.22 g/mol |
|---|---|
| Molecular Formula | C6H6N6O2S |
| XLogP3 | 0 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 1 |
| Exact Mass | 226.02729463 g/mol |
| Monoisotopic Mass | 226.02729463 g/mol |
| Topological Polar Surface Area | 144 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 261 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Megazol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Megazol, including repackagers and relabelers. The FDA regulates Megazol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Megazol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Megazol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Megazol supplier is an individual or a company that provides Megazol active pharmaceutical ingredient (API) or Megazol finished formulations upon request. The Megazol suppliers may include Megazol API manufacturers, exporters, distributors and traders.
click here to find a list of Megazol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Megazol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Megazol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Megazol GMP manufacturer or Megazol GMP API supplier for your needs.
A Megazol CoA (Certificate of Analysis) is a formal document that attests to Megazol's compliance with Megazol specifications and serves as a tool for batch-level quality control.
Megazol CoA mostly includes findings from lab analyses of a specific batch. For each Megazol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Megazol may be tested according to a variety of international standards, such as European Pharmacopoeia (Megazol EP), Megazol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Megazol USP).
LOOKING FOR A SUPPLIER?
